'Counting days to welcoming our incoming first-year fellows. University of Chicago Hematology/Oncology

Our faculty in the media!! Dr. Olson on ASCO Daily News talking about treatment & delivery of care in PD-1–Refractory Melanoma (dailynews.ascopubs.org/do/emerging-tr…) & coverage of Dr. Marina Garassino 's talk at ESMO on the MARIPOSA trial on Oncology Times (journals.lww.com/oncology-times…)!!

Welcome to our new University of Chicago Hem/Onc Fellows Chief Fellow, Dr. Abodunrin!! We can't wait to see what you do this year! 🎉

Thrilled to share our recent team science article unraveling TAM heterogeneity across PC disease spectrum & therapeutic targeting of "bad actor" SPP1+/TREM2+ TAM subsets in mCRPC: aacrjournals.org/mcr/article-ab… PCF Science University of Chicago Hematology/Oncology UChicagoCancerCenter UChicago Committee on Cancer Biology The V Foundation for Cancer Research

Welcome 🎉 We're so glad you're all here!!

A new Medical Stories segment is out/airing on PBS featuring Dr. Ari Rosenberg & one of his patients (who is also a former The University of Chicago employee!!). It's a beautiful episode & definitely worth a watch! You can find it at medicalstories.tv/title/head-and… #HeadNeckCancer #AtTheForefront

🔥 Hot off the press: In a new study, Cooperrider et al., show that lenalidomide drives expansion of high-risk TP53-mutant clones, which may predispose MM patients to secondary blood cancers like t-MDS and t-ALL. Caner Saygin, MD ⁦ Ben Derman University of Chicago Hematology/Oncology ow.ly/gvMO50WqIjj

Congratulations, Dr. Anand Patel!!!

Summer is the perfect time to learn more about sun safety and skin cancer prevention! Join today from 12-2!!

🎥 Andrzej Jakubowiak shares his insights on multiple myeloma updates EHA2025. -> medicaldigest.org/scientific-con… University of Chicago Hematology/Oncology UChicago Medicine European Hematology Association

🚨 Our faculty in the media!! 🚨 Dr. Soni Smith MD on Medscape weighing in on the #DLBCL debate: medscape.com/viewarticle/dl… and Dr. Kindler on MedPage Today talking about surgery in #mesothelioma medpagetoday.com/reading-room/a… ‼️

New article alert! 🚨🚨 Dr. Anand Patel and 3rd year University of Chicago Hem/Onc Fellows Dr. Yates are published in Haematologica sharing the results of the Consortium on Myeloid Malignancies and Neoplastic Diseases (COMMAND)! haematologica.org/article/view/1…

Cancer isn't just physically challenging, it's emotionally challenging. UChicago Medicine's Psychosocial Oncology Program helps cancer patients deal with all of those issues, from depression and stress to changes in sexual function. Learn more: uchicagomedicine.org/forefront/canc…

Save the date! 🗓️ This year's #JonasCenterSymposium on cellular therapy will be September 26 here on the The University of Chicago campus! Learn more/register at jonascentersymposium.com

Our "Explain Cancer to Me" comic on clinical trials is officially available in 11 languages!! English, Spanish, Polish, Arabic, Mandarin (both simplified and traditional), Hindi, Urdu, Tagalog, Polish, French, & Haitian Creole can all be found at voices.uchicago.edu/communitycance…

Proud of our cancer program for being #1 in Illinois for the 3rd year in a row!! Learn more about our USNWR rankings at uchicagomedicine.org/forefront/news…

Childhood Rhabdomyosarcoma requires expert care. UChicago’s pediatric oncology team is here for families. Explore here: ow.ly/xrNH50WbYHC #Rhabdomyosarcoma #PediatricCancer #CancerTreatment #UChicagoMedicine

Our faculty in the media (part 1)! 🎥 Dr. Szmulewitz is on NBC 5 Chicago talking about the rising rates of prostate cancer as the city mourns the death of Ryne Sandberg nbcchicago.com/video/local/vi…

Our faculty in the media (part 2)!! Our thoracic oncology team is shining, talking about new treatment regimens in NSCLC: Dr. Marina Garassino on OncLive.com onclive.com/view/new-immun… & Dr. Christine Bestvina is on Targeted Oncology targetedonc.com/view/kras-inhi…

Exciting news in the world of TIL therapy for #melanoma: our own Dr. Olson is the #1 physician in the nation relative to the infusion of commercial TIL for metastatic melanoma & our program is #3 overall in the nation! Thanks to this team for bringing patients cutting-edge care!